4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-000735
Options or other derivatives
- COO, GENERAL COUNSEL &CORP SEC acquired 120,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Belloff Neil S. · COO, GENERAL COUNSEL &CORP SEC
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-12 | Grant or award : show line 1 in the form Stock Options | +120,000 | 120,000 | D |
Loading xslF345X03/form4-02172021_030226.xml…